The Rising Tide
Tidal Psychedelics launched, poised to become largest psilocybin producer in Canada
2020 Health Canada approves psilocybin therapy for select patients with terminal illness.
2019 Denver, Oakland & Santa Cruz decriminalize mushrooms
FDA recognizes multiple alternate therapies, including MDMA for PTSD, synthetic psilocybin for Major Depressive Disorder and Treatment-Resistant Disorder
Delivering Global Excellence in
Tidal Psychedelics is crossing the divide between illness and wellness. A medical company first and foremost, Tidal is dedicated to advancing mental health and saving lives through the organic, micro-dosing of nature’s own psychedelic remedy.
Through its multi-pronged approach, Tidal is set to take its place as the leader in the global quest to address the mental health crisis through an effective, meaningful, long-term solution.
Tidal was founded by a team of doctors and business leaders with an interest in the use of psychedelics for assistance in dealing with brain injuries, PTSD, depression and end-of-life conditions
Canadians are affected by mental health issues by age 40
Canadians experiencing a depressive episode receive inadequate care
Canadians suffer from addiction
Canadians will suffer from PTSD in their lifetime